Platform, powered by AWS, connects patients, researchers, and clinicians to accelerate breakthroughs in gynecologic cancers NEW YORK, May 8, 2026 /PRNewswire/ -- Ovarian Cancer Research Alliance (OCRA) today announced the launch of the Community Accelerated Research Exchange, a first-of-its-kind, global, AI-powered ecosystem designed to transform how gynecologic cancer research is conducted—accelerating breakthroughs by connecting patients, clinicians, researchers, and advocates in real time. De

BRISBANE, Calif., May 08, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies to transform the lives of patients, today announced the granting of inducement awards on May 4, 2026 to ten new employees under Pacira’s Amended and Restated 2014 Inducement Plan (the “Inducement Plan”) as a material inducement to each employee’s entry into employment with the company. In accordance with Nasdaq Listing Rule 563

Dr. Wilson joins an elite, invitation-only assembly of the nation's most influential health care leaders and policymakers shaping the future of American medicine GIG HARBOR, Wash., May 8, 2026 /PRNewswire/ -- NorthStar, a pioneering force in technology-enabled, evidence-based addiction treatment, today announced that Dr. Amanda Wilson, CEO and Co-Founder, has been appointed to The Washington Post Intelligence Health Care Council—an exclusive, invitation-only body of the most influential senior e

ROCKVILLE, Md., May 8, 2026 /PRNewswire/ -- USA -- AAVnerGene Inc. today announced the launch of AAVone®2.1, the next-generation evolution of its proprietary AAVone® single-plasmid AAV production system, designed to improve AAV vector productivity, full-capsid yield, manufacturing efficiency, and cost effectiveness. Continue Reading AAV2.1, achieving ~1e16GC/L and >70% Full Capsids at Harvest AAVone®2.1 has achieved ~1x1016 genome copies (GC)/L of cell culture and greater than 70% full capsids a

Amazon Pharmacy announced it will offer pharma giant Novo Nordisk's Ozempic pill, which received FDA approval earlier this year, for home delivery or pickup via an in-office kiosk through its digital pharmacy. ​The Ozempic pill is a GLP-1 used to treat Type 2 diabetes. It was not approved by the FDA as a weight-loss drug. Amazon Pharmacy said it will offer same-day prescription delivery and pickup within minutes through its kiosks at select One Medical locations. ​Same-day delivery services will

TORONTO, May 08, 2026 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing and commercialisation of plant-derived cannabinoid-based products is pleased to announce that all of management’s nominees listed in the Company’s management information circular dated April 2, 2026 (“Circular”) were elected as directors of the Company at its Annual General and Special Meeting of Shareholder

BOSTON--(BUSINESS WIRE)--Today, STAAR Low-Grade Serous Ovarian Cancer Foundation, Not These Ovaries, and Verastem Oncology announced the launch of the LGSOC Resource Guide, a unique resource designed to support patients living with low-grade serous ovarian cancer (LGSOC), a rare and distinct form of ovarian cancer, along with their caregivers and advocates. Available at www.LGSOCAwarenessDay.org, the guide launches in conjunction with World Ovarian Cancer Day, a global effort to raise awareness

PRINCETON, N.J., May 8, 2026 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today its recent updates and financial results for the quarter ended March 31, 2026. "We remain disappointed with the unanticipated outcome of the FLASH2 (Fluorescent Light Activated Synthetic Hypericin 2) study," stated Christopher J.

🗓️ FDA delays subcutaneous Leqembi decision: Originally slated for later this month, the decision date now falls on August 24, Biogen and Eisai said . The agency asked for more information from the companies, constituting a “major amendment” to the application. — Max Gelman 🚀 Artiva touts rheumatoid arthritis data, prices $300M raise: The biotech said five of seven patients responded to its off-the-shelf NK cell therapy, seeing their disease improve by at least 50% after six months. Artiva $AR

On World Ovarian Cancer Day, May 8, the Global Ovarian Cancer Research Consortium announces a second $1 million USD grant along with AWS compute support to power research to improve ovarian cancer survival ratesTORONTO, May 08, 2026 (GLOBE NEWSWIRE) -- On World Ovarian Cancer Day the Global Ovarian Cancer Research Consortium, of which Ovarian Cancer Canada is a founding partner, today announced the launch of its second $1 million USD AI Accelerator Grant, a major research initiative designed t